+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Situ Hybridization Market by Product, Technology, Application, End User - Global Forecast 2025-2030- Product Image
In Situ Hybridization Market by Product, Technology, Application, End User - Global Forecast 2025-2030- Product Image
Sale

In Situ Hybridization Market by Product, Technology, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5137193
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In Situ Hybridization Market grew from USD 1.81 billion in 2023 to USD 1.94 billion in 2024. It is expected to continue growing at a CAGR of 7.92%, reaching USD 3.10 billion by 2030.

In situ hybridization (ISH) is a powerful molecular technique used to localize specific nucleic acid targets within fixed tissues and cells, enabling researchers and clinicians to assess gene expression and genomic arrangements. The demand for ISH is driven by its necessity in various applications, including cancer diagnostics, cytogenetics, neuroscience research, and infectious disease diagnosis. Its end-use scope is extensive, serving hospitals, academic research institutes, diagnostic laboratories, and biotechnology companies. Advancements in ISH methodologies, such as fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH), are key growth drivers by enhancing accuracy and application breadth.

Market insights point towards a growing emphasis on personalized medicine and precision diagnostics as pivotal growth factors. The increasing incidence of cancer and genetic disorders further propels the demand for ISH techniques that aid in early detection and treatment planning. Recent advancements in digital pathology and automated ISH systems present immense potential opportunities by streamlining operations and improving throughput and accuracy. To seize these opportunities, market players should invest in research and development of novel probes and automated platforms, expanding their application across emerging fields like single-cell genomics.

However, limitations such as high costs, technical complexity, and the need for skilled personnel pose significant challenges to market growth. Additionally, stringent regulatory environments for diagnostic tools can impede rapid market expansion. To address these challenges, continuous innovation focused on cost reduction and simplifying ISH procedures can be pivotal. Areas ripe for innovation include the development of more robust and multiplexed ISH assays, which could facilitate more comprehensive diagnostics and research outcomes. The market continues to evolve, characterized by technological advancements and increased collaborations among biotechnology firms, academic institutions, and healthcare providers. By focusing on automation, simplifying workflows, and enhancing the multiplexing capabilities of ISH techniques, businesses can harness substantial growth and maintain competitive advantage in this nuanced market.

Understanding Market Dynamics in the In Situ Hybridization Market

The In Situ Hybridization Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of infectious diseases demanding rapid diagnostic techniques
    • Rising inclination towards molecular diagnostic tools
    • Increasing investments in R&D pertaining to IVD
  • Market Restraints
    • Limitation in identifying the low DNA and RNA sequencing
  • Market Opportunities
    • Rapid advent of 3D fluorescence in situ hybridization (FISH) technologies
    • Technological advancements and strategic investments to develop ISH technologies
  • Market Challenges
    • Concerns regarding lack of skilled professionals to provide proper diagnosis

Exploring Porter’s Five Forces for the In Situ Hybridization Market

Porter’s Five Forces framework further strengthens the insights of the In Situ Hybridization Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the In Situ Hybridization Market

External macro-environmental factors deeply influence the performance of the In Situ Hybridization Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the In Situ Hybridization Market

The In Situ Hybridization Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the In Situ Hybridization Market

The In Situ Hybridization Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the In Situ Hybridization Market

The In Situ Hybridization Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the In Situ Hybridization Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Abnova Corporation, Advanced Cell Diagnostics, Inc., Agilent Technologies, Inc., Bio SB, Bio-Rad Laboratories, Inc., Biocare Medical, LLC, BioCat GmbH, Bioevopeak Co., Ltd. |, BioGenex Laboratories, Biomers.net GmbH, BioView Ltd., Cell Line Genetics, Inc., CellCarta Biosciences Inc., Charles River Laboratories International, Inc., CiteAb Ltd., Cole-Parmer Instrument Company, LLC., Creative Bioarray, Creative Biolabs, Daicel Arbor Biosciences, DSS Imagetech Pvt. Ltd., Emsurg Healthcare (India) Pvt. Limited, Enzo Life Sciences, Inc., Excilone, F. Hoffmann-La Roche Ltd, Flogentec, GeneDetect.com Limited, Intertek Group PLC, KromaTiD Inc., Leica Biosystems Nussloch GmbH, Merck KGaA, Molecular Instruments, Inc., NeoGenomics Laboratories, Inc., Okabé Bureau, Opgen, Oxford Gene Technology IP Limited, PerkinElmer Inc., Qiagen N.V., QIMA Life Sciences, Reveal Biosciences, Inc., Ribocon GmbH, Spatial Genomics, Inc., Stratech Scientific Ltd, Suraksha Diagnostic Private Limited, Thermo Fisher Scientific Inc., Vector Laboratories, Inc., Zytomed Systems GmbH, and ZytoVision GmbH.

Market Segmentation & Coverage

This research report categorizes the In Situ Hybridization Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Consumables
      • Accessories
      • Kits & Reagents
      • Probes
    • Instruments
    • Software
  • Technology
    • Chromogenic In Situ Hybridization
    • Fluorescence In Situ Hybridization
      • DNA Fluorescence In Situ Hybridization
      • PNA Fluorescence In Situ Hybridization
      • RNA Fluorescence In Situ Hybridization
  • Application
    • Cancer Diagnostics
    • Cytology
    • Immunology
    • Infectious Disease Diagnostics
    • Neuroscience
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospital & Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of infectious diseases demanding rapid diagnostic techniques
5.1.1.2. Rising inclination towards molecular diagnostic tools
5.1.1.3. Increasing investments in R&D pertaining to IVD
5.1.2. Restraints
5.1.2.1. Limitation in identifying the low DNA and RNA sequencing
5.1.3. Opportunities
5.1.3.1. Rapid advent of 3D fluorescence in situ hybridization (FISH) technologies
5.1.3.2. Technological advancements and strategic investments to develop ISH technologies
5.1.4. Challenges
5.1.4.1. Concerns regarding lack of skilled professionals to provide proper diagnosis
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. In Situ Hybridization Market, by Product
6.1. Introduction
6.2. Consumables
6.2.1. Accessories
6.2.2. Kits & Reagents
6.2.3. Probes
6.3. Instruments
6.4. Software
7. In Situ Hybridization Market, by Technology
7.1. Introduction
7.2. Chromogenic In Situ Hybridization
7.3. Fluorescence In Situ Hybridization
7.3.1. DNA Fluorescence In Situ Hybridization
7.3.2. PNA Fluorescence In Situ Hybridization
7.3.3. RNA Fluorescence In Situ Hybridization
8. In Situ Hybridization Market, by Application
8.1. Introduction
8.2. Cancer Diagnostics
8.3. Cytology
8.4. Immunology
8.5. Infectious Disease Diagnostics
8.6. Neuroscience
9. In Situ Hybridization Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Hospital & Diagnostic Laboratories
9.5. Pharmaceutical & Biotechnology Companies
10. Americas In Situ Hybridization Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific In Situ Hybridization Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa In Situ Hybridization Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Biocare Medical Acquires Empire Genomics | Precision Oncology News
13.3.2. Resolve Biosciences Raises $71M in Series B Financing
13.3.3. Danaher To Acquire Aldevron
13.3.4. PNI to be Acquired by Danaher Corporation’s Life Sciences Platform
13.3.5. Bio-Techne has announced the commercial release of novel DNAscope in situ hybridization assays
13.3.6. Avacta Announces Distribution Agreement With ABCAM plc | Business Wire
13.3.7. FDA approves Roche’s Ventana ALK (D5F3) CDx Assay for lung cancer
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. IN SITU HYBRIDIZATION MARKET RESEARCH PROCESS
FIGURE 2. IN SITU HYBRIDIZATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. IN SITU HYBRIDIZATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. IN SITU HYBRIDIZATION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. IN SITU HYBRIDIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. IN SITU HYBRIDIZATION MARKET DYNAMICS
TABLE 7. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CHROMOGENIC IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY DNA FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PNA FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY RNA FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 54. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 60. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 86. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 88. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 92. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 94. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 104. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 106. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 140. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 142. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 157. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 159. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 161. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 165. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 167. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 171. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 177. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 183. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 195. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 197. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 213. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 219. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 221. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 225. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 227. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 249. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 251. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 266. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 267. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 269. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. IN SITU HYBRIDIZATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. IN SITU HYBRIDIZATION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the In Situ Hybridization Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Abcam Plc
  • Abnova Corporation
  • Advanced Cell Diagnostics, Inc.
  • Agilent Technologies, Inc.
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Biocare Medical, LLC
  • BioCat GmbH
  • Bioevopeak Co., Ltd. |
  • BioGenex Laboratories
  • Biomers.net GmbH
  • BioView Ltd.
  • Cell Line Genetics, Inc.
  • CellCarta Biosciences Inc.
  • Charles River Laboratories International, Inc.
  • CiteAb Ltd.
  • Cole-Parmer Instrument Company, LLC.
  • Creative Bioarray
  • Creative Biolabs
  • Daicel Arbor Biosciences
  • DSS Imagetech Pvt. Ltd.
  • Emsurg Healthcare (India) Pvt. Limited
  • Enzo Life Sciences, Inc.
  • Excilone
  • F. Hoffmann-La Roche Ltd
  • Flogentec
  • GeneDetect.com Limited
  • Intertek Group PLC
  • KromaTiD Inc.
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • Molecular Instruments, Inc.
  • NeoGenomics Laboratories, Inc.
  • Okabé Bureau
  • Opgen
  • Oxford Gene Technology IP Limited
  • PerkinElmer Inc.
  • Qiagen N.V.
  • QIMA Life Sciences
  • Reveal Biosciences, Inc.
  • Ribocon GmbH
  • Spatial Genomics, Inc.
  • Stratech Scientific Ltd
  • Suraksha Diagnostic Private Limited
  • Thermo Fisher Scientific Inc.
  • Vector Laboratories, Inc.
  • Zytomed Systems GmbH
  • ZytoVision GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.1 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned50

Related Topics

Related Reports

Fluorescence In Situ Hybridization Imaging Systems Market Size, Share & Trends Analysis Report By Product (Instruments), By Application (Cancer Diagnosis), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Fluorescence In Situ Hybridization Imaging Systems Market Size, Share & Trends Analysis Report By Product (Instruments), By Application (Cancer Diagnosis), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
In Situ Hybridization Market Size, Share & Trends Analysis Report by Technology (FISH, CISH), Probe Type (DNA, RNA), Product (Instrument, Consumables & Accessories, Software, Services), Application, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

In Situ Hybridization Market Size, Share & Trends Analysis Report by Technology (FISH, CISH), Probe Type (DNA, RNA), Product (Instrument, Consumables & Accessories, Software, Services), Application, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
In Situ Hybridization (ISH) - Global Strategic Business Report - Product Image

In Situ Hybridization (ISH) - Global Strategic Business Report

  • Report
  • 504 Pages
  • Global
From
In Situ Hybridization Global Market Report 2024 - Product Image

In Situ Hybridization Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Fluorescent in Situ Hybridization (FISH) Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Fluorescent in Situ Hybridization (FISH) Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From

About the Market

In Situ Hybridization (ISH) is a molecular diagnostic technique used to detect and localize specific nucleic acid sequences within cells and tissues. It is used to detect gene expression, chromosomal abnormalities, and gene mutations. ISH is a powerful tool for diagnosing diseases such as cancer, genetic disorders, and infectious diseases. ISH involves the use of labeled probes, which are complementary to the target nucleic acid sequence. The probes are hybridized to the target sequence, and the labeled probes are detected using a variety of techniques, such as fluorescence microscopy, immunohistochemistry, and in situ PCR. ISH is used in a variety of clinical applications, including the diagnosis of cancer, genetic disorders, and infectious diseases. It is also used in research to study gene expression, chromosomal abnormalities, and gene mutations. Companies in the In Situ Hybridization market include Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.